20 completed, 5 unknown, 2 active not recruiting, 2 not yet recruiting. 10 Not applicable, 9 Phase 2, 7 Phase 3, 4 Early Phase 1, 4 Phase 1.
Follow CoQ10: new trials by email Literature Review of CoQ10 trials Research Report on CoQ10
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Guishen Yijing Granules for Diminished Ovarian Reserve With Kidney Deficiency Syndrome: A Randomized Controlled Trial Guishen Yijing Granules, Coenzyme Q10 (drug) - Diminished Ovarian Reserve (DOR) | Early Phase 1 | Not yet recruiting | Shi Yun | 120 | 2026-09-22 | 2026-09-25 |
| Renoprotective Role of Vitamin C and Coenzyme Q10 in Nephrotoxicity Vitamin C, Coenzyme Q 10 - Nephrotoxicity | Phase 2 / Phase 3 | Not yet recruiting | Ain Shams University | 75 | 2026-04-20 | 2026-03-17 |
| Reducing Fatigue With CoQ10 Supplementation in Patients With Crohn's Disease Study CoQ10 - Crohn Disease, Healthy | Early Phase 1 | Active not recruiting | University of Pennsylvania | 60 | 2024-07-20 | 2026-10-09 |
| Evaluation the Effect of Coenzyme Q10 on Tissue Healing Process in Patients Undergoing Wisdom Tooth Extraction Coenzyme Q10 100 MG Oral Tablet, Placebo - Molar, Third, Temporomandibular Joint Disorders | Phase 4 | Unknown | Zahra Nejati | 70 | 2024-07-01 | 2024-06-11 |
| The Effect of Jiajian Guishen Granules on the Modulation of Ovarian Function in Patients With Poor Ovarian Response(POR) Jiajian Guishen granules, coenzyme Q10 - Poor Ovarian Response | Early Phase 1 | Unknown | Shi Yun | 76 | 2024-06-01 | 2024-05-02 |
| Effect Supplementation of COenzyme Q10 in Acute STEMI Underwent PPCI Coenzyme Q 10, Placebo - ST Segment Elevation Myocardial Infarction (STEMI), Coenzyme Q10 | Not applicable | Completed | Universitas Diponegoro | 46 | 2024-01-28 | 2024-10-28 |
| Vestibular Function Using Mitochondrial Antioxidant Therapy Alpha Lipoic Acid 300mg, Coenzyme Q10 200mg - Vestibular Function Disorder | Early Phase 1 | Withdrawn | The University of Texas Health Science Center at San Antonio | 2024-01-01 | 2023-10-18 | |
| CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease CoQ10, Placebo, HB-HIIT - End Stage Renal Disease | Phase 3 | Recruiting | Vanderbilt University Medical Center | 156 | 2023-06-01 | 2026-01-02 |
| Pharmacokinetics of Different CoQ10 Formulations CoQ10 - Coenzyme Q10 Pharmacokinetics | Not applicable | Completed | Factors Group of Nutritional Companies Inc. | 15 | 2022-03-01 | 2023-12-05 |
| Watermelon/UBIQuinone Study coenzyme Q10, Watermelon diet, Usual Diet - Kidney Transplantation | Not applicable | Active not recruiting | University of California, San Francisco | 70 | 2021-11-15 | 2025-07-14 |
| Coenzyme Q10 and Meclofenoxate in Hepatic Encephalopathy Coenzyme Q10, MECLOFENOXATE - Hepatic Encephalopathy, Coenzyme Q10 | Not applicable | Unknown | Zagazig University | 300 | 2019-05-23 | 2019-07-18 |
| Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease CoQ10, Nicotinamide riboside, Placebo - Chronic Kidney Disease, Sarcopenia | Phase 2 | Completed | University of Washington | 26 | 2018-11-14 | 2023-01-10 |
| Efficacy of Coenzyme Q10 Supplementation on Multi-Organ Dysfunction in Severely Burned Patients CoQ10, Placebo - Multiple Organ Failure | Phase 3 | Withdrawn | American Burn Association | 2018-07-01 | 2023-07-20 | |
| CoQ10 and D-ribose in Patients With Diastolic Heart Failure CoQ10, D-Ribose Oral Powder, Placebo pills - Heart Failure, Diastolic | Phase 2 | Completed | University of Kansas Medical Center | 216 | 2018-02-05 | 2022-03-18 |
| Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest Ubiquinol, Ensure - Cardiac Arrest | Phase 2 | Completed | Beth Israel Deaconess Medical Center | 48 | 2016-03-01 | 2021-02-15 |
| A Safety Study of Orally Administered BPM31510 in Healthy Subjects BPM31510 Oral Nanosuspension 4% - Healthy | Phase 1 | Completed | BPGbio | 20 | 2015-11-01 | 2016-12-22 |
| Aneuploidy Rates in Advanced Maternal Age Patients Supplemented With Coenzyme Q10 (CoQ10) Versus Those That Are Not: a Pilot Study CoQ10, Placebo - Mitochondrial DNA, Aneuploidy | Not applicable | Completed | Reproductive Endocrinology Associates of Charlotte | 21 | 2014-04-01 | 2018-05-04 |
| Beneficial Effects of Coenzyme Q10 Treatment on the Mitochondrial Dysfunction and Oxidative Stress Associated to Atherothrombosis Developement in Antiphospholipidid Syndrome Patients CoQ10, Placebo - Coenzyme Q10 on Athero-thrombosis in APS Patients | Not applicable | Unknown | Maimónides Biomedical Research Institute of Córdoba | 50 | 2013-09-01 | 2014-08-18 |
| Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10 CoQ10, Sanomit Placebo - Ataxia-oculomotor Apraxia 1 | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 19 | 2013-06-01 | 2017-11-06 |
| CoQ10 Biomarker Trial Coenzyme Q10, Placebo - Oxidative Stress, Inflammation | Not applicable | Completed | University of Washington | 66 | 2011-11-01 | 2014-12-04 |
Showing 20 of 33. Sign in to see all of them.
Cardiovascular Diseases (4) · Kidney Failure, Chronic (3) · Atherosclerosis (2) · Frailty (2) · Mitochondrial Diseases (2) · Sarcopenia (2) · Supranuclear Palsy, Progressive (2) · Amyotrophic Lateral Sclerosis (1) · Aneuploidy (1) · Breast Neoplasms (1) · Charcot-Marie-Tooth Disease (1) · Coronary Disease (1) · Crohn Disease (1) · Dry Socket (1) · Early-onset ataxia with oculomotor apraxia and hypoalbuminemia (1)
University of Washington (3) · Columbia University (2) · Lahey Clinic (2) · Shi Yun (2) · Ain Shams University (1) · American Burn Association (1) · Assistance Publique - Hôpitaux de Paris (1) · BPGbio (1) · Beth Israel Deaconess Medical Center (1) · Cooperative International Neuromuscular Research Group (1) · Factors Group of Nutritional Companies Inc. (1) · Federico II University (1) · Hartford Hospital (1) · Johns Hopkins University (1) · Maimónides Biomedical Research Institute of Córdoba (1)
United States (22) · Canada (2) · Egypt (2) · China (1) · France (1) · Indonesia (1) · Italy (1) · Spain (1)
Diana Apetauerova, MD (2) · Jonathan Himmelfarb, MD (2) · Amr S Hanafy, M.D (1) · Baback Roshanravan, MD (1) · Baback Roshanravan, MD/MPH (1) · Barbara Tilley, Ph.D. (1) · Brian Perry, MD (1) · Bruno Trimarco, MD (1) · Bryan Kestenbaum, MD (1) · Christopher A Ross, MD, PhD (1) · Chunmei Wang (1) · Dugald Seely, ND (1) · Elaine Ku (1) · Haiyun Sun (1) · Heather Greenlee, ND, PhD (1)
PMID 11393894, PMID 15346752, PMID 16022079, PMID 16190504, PMID 16243238, PMID 17718279, PMID 17935805, PMID 19557369, PMID 19743457, PMID 19751357, PMID 21829786, PMID 22114445, PMID 22252298, PMID 22263004, PMID 22338284, PMID 22645047, PMID 23582186, PMID 23630244, PMID 23647782, PMID 24451612, PMID 24711047, PMID 24878832, PMID 25170946, PMID 25301877, PMID 25545331, PMID 25822556, PMID 26070801, PMID 26428323, PMID 26531095, PMID 26614696, PMID 26630268, PMID 27406490, PMID 27583276, PMID 27795646, PMID 27993387, PMID 28068790, PMID 28252213, PMID 28684614, PMID 28824306, PMID 29606104, PMID 29732309, PMID 29756084, PMID 30405935, PMID 31082170, PMID 31604558, PMID 31735229, PMID 31886806, PMID 31915512, PMID 3203526, PMID 32188600
R21AT004265 (2), P30AG044271 (1), R01AG054486 (1), R01DK101509 (1), R01NS048125 (1), U01NS043128 (1)